• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大规模生物反应器中CHO细胞培养过程的放大分析。

Scale-up analysis for a CHO cell culture process in large-scale bioreactors.

作者信息

Xing Zizhuo, Kenty Brian M, Li Zheng Jian, Lee Steven S

机构信息

Process Sciences, Biologics Manufacturing and Process Development, Worldwide Medicines Group, Bristol-Myers Squibb Company, Syracuse, NY 13221-4755, USA.

出版信息

Biotechnol Bioeng. 2009 Jul 1;103(4):733-46. doi: 10.1002/bit.22287.

DOI:10.1002/bit.22287
PMID:19280669
Abstract

Bioprocess scale-up is a fundamental component of process development in the biotechnology industry. When scaling up a mammalian cell culture process, it is important to consider factors such as mixing time, oxygen transfer, and carbon dioxide removal. In this study, cell-free mixing studies were performed in production scale 5,000-L bioreactors to evaluate scale-up issues. Using the current bioreactor configuration, the 5,000-L bioreactor had a lower oxygen transfer coefficient, longer mixing time, and lower carbon dioxide removal rate than that was observed in bench scale 5- and 20-L bioreactors. The oxygen transfer threshold analysis indicates that the current 5,000-L configuration can only support a maximum viable cell density of 7 x 10(6) cells mL(-1). Moreover, experiments using a dual probe technique demonstrated that pH and dissolved oxygen gradients may exist in 5,000-L bioreactors using the current configuration. Empirical equations were developed to predict mixing time, oxygen transfer coefficient, and carbon dioxide removal rate under different mixing-related engineering parameters in the 5,000-L bioreactors. These equations indicate that increasing bottom air sparging rate is more efficient than increasing power input in improving oxygen transfer and carbon dioxide removal. Furthermore, as the liquid volume increases in a production bioreactor operated in fed-batch mode, bulk mixing becomes a challenge. The mixing studies suggest that the engineering parameters related to bulk mixing and carbon dioxide removal in the 5,000-L bioreactors may need optimizing to mitigate the risk of different performance upon process scale-up.

摘要

生物过程放大是生物技术产业过程开发的一个基本组成部分。在放大哺乳动物细胞培养过程时,考虑混合时间、氧气传递和二氧化碳去除等因素很重要。在本研究中,在生产规模的5000升生物反应器中进行了无细胞混合研究,以评估放大问题。使用当前的生物反应器配置,5000升生物反应器的氧气传递系数较低、混合时间较长且二氧化碳去除率低于在实验室规模的5升和20升生物反应器中观察到的情况。氧气传递阈值分析表明,当前的5000升配置仅能支持最大活细胞密度为7×10⁶个细胞/毫升。此外,使用双探针技术的实验表明,采用当前配置的5000升生物反应器中可能存在pH值和溶解氧梯度。开发了经验方程来预测5000升生物反应器中不同混合相关工程参数下的混合时间、氧气传递系数和二氧化碳去除率。这些方程表明,在改善氧气传递和二氧化碳去除方面,提高底部空气喷射速率比增加功率输入更有效。此外,随着分批补料模式下运行的生产生物反应器中液体体积的增加,整体混合成为一项挑战。混合研究表明,5000升生物反应器中与整体混合和二氧化碳去除相关的工程参数可能需要优化,以降低过程放大时性能差异的风险。

相似文献

1
Scale-up analysis for a CHO cell culture process in large-scale bioreactors.大规模生物反应器中CHO细胞培养过程的放大分析。
Biotechnol Bioeng. 2009 Jul 1;103(4):733-46. doi: 10.1002/bit.22287.
2
Culture scale-up studies as seen from the viewpoint of oxygen supply and dissolved carbon dioxide stripping.从氧气供应和溶解二氧化碳去除的角度看培养放大研究。
J Biosci Bioeng. 2009 Apr;107(4):412-8. doi: 10.1016/j.jbiosc.2008.12.016.
3
A predictive high-throughput scale-down model of monoclonal antibody production in CHO cells.CHO 细胞中单克隆抗体生产的高通量预测性缩小模型。
Biotechnol Bioeng. 2009 Dec 15;104(6):1107-20. doi: 10.1002/bit.22474.
4
Novel micro-bioreactor high throughput technology for cell culture process development: Reproducibility and scalability assessment of fed-batch CHO cultures.新型微生物反应器高通量技术在细胞培养工艺开发中的应用:补料分批 CHO 培养的重现性和可扩展性评估。
Biotechnol Bioeng. 2010 May 1;106(1):57-67. doi: 10.1002/bit.22664.
5
Fed-batch bioreactor process scale-up from 3-L to 2,500-L scale for monoclonal antibody production from cell culture.从3升规模到2500升规模的补料分批生物反应器工艺放大,用于细胞培养生产单克隆抗体。
Biotechnol Bioeng. 2007 Sep 1;98(1):141-54. doi: 10.1002/bit.21413.
6
Estimation of dissolved carbon dioxide stripping in a large bioreactor using model medium.使用模型培养基估算大型生物反应器中溶解二氧化碳的汽提情况。
J Biosci Bioeng. 2009 Apr;107(4):419-24. doi: 10.1016/j.jbiosc.2008.11.017.
7
Quantification of power consumption and oxygen transfer characteristics of a stirred miniature bioreactor for predictive fermentation scale-up.用于预测发酵放大的搅拌式微型生物反应器的功耗和氧传递特性的量化
Biotechnol Bioeng. 2008 Aug 15;100(6):1144-55. doi: 10.1002/bit.21852.
8
A comprehensive comparison of mixing, mass transfer, Chinese hamster ovary cell growth, and antibody production using Rushton turbine and marine impellers.使用涡轮桨和船用推进器对混合、传质、中国仓鼠卵巢细胞生长和抗体生产进行全面比较。
Bioprocess Biosyst Eng. 2011 Sep;34(7):819-32. doi: 10.1007/s00449-011-0532-0. Epub 2011 Apr 20.
9
Bioreactor scale-up and oxygen transfer rate in microbial processes: an overview.微生物过程中的生物反应器放大与氧传递速率:综述
Biotechnol Adv. 2009 Mar-Apr;27(2):153-76. doi: 10.1016/j.biotechadv.2008.10.006. Epub 2008 Nov 12.
10
Development, parallelization, and automation of a gas-inducing milliliter-scale bioreactor for high-throughput bioprocess design (HTBD).用于高通量生物工艺设计(HTBD)的气体诱导毫升级生物反应器的开发、并行化和自动化。
Biotechnol Bioeng. 2005 Mar 5;89(5):512-23. doi: 10.1002/bit.20352.

引用本文的文献

1
Engineering Characterization of Small-Scale Bioreactors for Large-Scale hiPSC Production.用于大规模人诱导多能干细胞生产的小型生物反应器的工程表征
Biotechnol J. 2025 Sep;20(9):e70106. doi: 10.1002/biot.70106.
2
Scalable production process development for NK cells targeting large-scale expansion.用于靶向大规模扩增的自然杀伤细胞的可扩展生产工艺开发。
Regen Ther. 2025 Aug 5;30:535-543. doi: 10.1016/j.reth.2025.07.014. eCollection 2025 Dec.
3
Characterization of factors that influence rAAV yield and quality when produced using rHSV co-infection.
使用重组单纯疱疹病毒(rHSV)共感染生产时影响重组腺相关病毒(rAAV)产量和质量的因素的表征。
Mol Ther Methods Clin Dev. 2025 Apr 17;33(2):101471. doi: 10.1016/j.omtm.2025.101471. eCollection 2025 Jun 12.
4
Optimization of Culture Conditions to Improve Follicle-Stimulating Hormone Production by CHO-DG44 Cells in Serum-Free Medium.优化培养条件以提高无血清培养基中CHO-DG44细胞促卵泡激素的产量
Iran Biomed J. 2024 Sep 1;28(5 & 6):282-96. doi: 10.61186/ibj.4160.
5
Scale-up of CHO cell cultures: from 96-well-microtiter plates to stirred tank reactors across three orders of magnitude.中国仓鼠卵巢细胞培养的放大:从96孔微量滴定板到搅拌罐反应器,跨越三个数量级。
J Biol Eng. 2025 Jan 15;19(1):5. doi: 10.1186/s13036-024-00475-8.
6
Bench-Scale Stirred-Tank Bioreactor for Recombinant Protein Production in Chinese Hamster Ovary (CHO) Cells in Suspension.用于在悬浮 CHO 细胞中生产重组蛋白的台式搅拌槽生物反应器。
Methods Mol Biol. 2024;2810:235-247. doi: 10.1007/978-1-0716-3878-1_15.
7
Enhancing and stabilizing monoclonal antibody production by Chinese hamster ovary (CHO) cells with optimized perfusion culture strategies.通过优化灌注培养策略提高和稳定中国仓鼠卵巢(CHO)细胞的单克隆抗体产量。
Front Bioeng Biotechnol. 2023 Jan 20;11:1112349. doi: 10.3389/fbioe.2023.1112349. eCollection 2023.
8
Scaling-down biopharmaceutical production processes via a single multi-compartment bioreactor (SMCB).通过单个多隔室生物反应器(SMCB)缩小生物制药生产工艺规模。
Eng Life Sci. 2022 Mar 14;23(1):e2100161. doi: 10.1002/elsc.202100161. eCollection 2023 Jan.
9
End-to-End Approach to Surfactant Selection, Risk Mitigation, and Control Strategies for Protein-Based Therapeutics.端到端方法用于表面活性剂选择、蛋白质类治疗药物的风险缓解和控制策略。
AAPS J. 2022 Dec 5;25(1):6. doi: 10.1208/s12248-022-00773-3.
10
A Brief Review of Plant Cell Transfection, Gene Transcript Expression, and Genotypic Integration for Enhancing Compound Production.植物细胞转染、基因转录表达和基因型整合的简要综述,以提高化合物的产量。
Methods Mol Biol. 2023;2575:153-179. doi: 10.1007/978-1-0716-2716-7_8.